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SUMMARY 
Background: Insulin is an important metabolic hormone that also has cardiovascular effects. 
Insulin resistance is characterized by decreased tissue sensitivity to insulin, and is a part of two 
important endocrine diseases in horses, Equine Metabolic Syndrome and Pituitary Pars 
Intermedia Dysfunction. Both diseases carry an increased risk for laminitis. 
 
Decreased insulin sensitivity in people has been shown to lead to a decrease of the vasodilating 
effect of insulin. Increased baseline blood pressure and heart rate have also been seen in insulin 
resistant dogs and rats. The effect of induced hyperinsulinemia on cardiovascular markers such 
as heart rate, blood pressure and peripheral blood flow has been studied in healthy as well as 
insulin resistant people and laboratory animals. Studies regarding the effect of insulin resistance 
and induced hyperinsulinemia on cardiovascular markers in horses are scarce. The purpose of 
this study was to compare heart rate, blood pressure and hoof wall surface temperature (HWST) 
in insulin resistant horses with controls and to study the effect of hyperinsulinemia. 
 
Method: Ten insulin resistant (IR) horses and four healthy controls were included in the study. 
A 180 min euglycemic-hyperinsulinemic clamp (EHC) was performed in all horses. All horses 
were evaluated for body condition. Heart rate and systemic blood pressure was recorded before 
the start of the insulin infusion and at 45, 105 and 165 min of insulin infusion. Hoof wall surface 
temperature was recorded continuously during the 180 min EHC, starting 45 min before 
infusion start to obtain baseline temperatures. Blood samples for serum insulin and glucose 
were taken at 10 min intervals during the entire EHC, and insulin sensitivity was assessed from 
calculation of metabolized glucose per unit insulin (M/I ratio, with < 5 considered insulin 
resistant). 
 
Results: Insulin resistant horses had higher baseline heart rates than control horses, and heart 
rate was positively associated with body condition score. There was no difference in systemic 
blood pressure or hoof wall surface temperatures between groups. Insulin infusion caused a 
decrease in systolic blood pressure in the control group, but not in the IR group. The induced 
hyperinsulinemia did not influence heart rate, mean arterial blood pressure, diastolic blood 
pressure or hoof wall surface temperature in either group. 
 
Conclusion:  
This study indicates that horses with insulin resistance have higher baseline heart rates 
compared to controls and that heart rate is associated with BCS.  There are also indications that 
insulin resistant horses might have an altered cardiovascular response to hyperinsulinemia.  
Further studies are needed to validate this result, preferably with greater sample sizes and using 
different breeds of horses.  
 
 
 
  
SAMMANFATTNING 
Bakgrund: Insulin är ett viktigt metabolt hormon som även har kardiovaskulära effekter, dels 
genom kärlpåverkan men även genom stimulans av sympatiska nervsystemet. Insulinresistens  
är ett syndrom som innebär nedsatt känslighet för insulin och ingår i hästsjukdomarna Ekvint 
metabolt syndrom och Pituitary Pars Intermedia Dysfunction hos hästar, vilka båda medför 
ökad risk för fång.  
 
På människa har nedsatt insulinkänslighet visat sig minska  insulinets vasodilaterande effekt 
vilket leder till hypertension. På människa och försöksdjur har man studerat insulinets effekter 
på kardiovaskulära markörer såsom hjärtfrekvens, blodtryck och perifert blodflöde både på 
insulinresistenta individer och på individer med normal insulinkänslighet. Studier avseende 
effekten av insulinresistens och hyperinsulimemi på kardiovaskulära markörer på häst är få. 
Syftet med den här studien var att jämföra hjärtfrekvens, blodtryck och hovtemperatur hos 
insulinresistenta hästar med hästar med normal insulinkänslighet samt studera effekten av 
hyperinsulinemi. 
 
Metod: Tio insulinresistenta hästar och fyra friska kontroller med normal insulinkänslighet 
genomgick en euglycemisk-hyperinsulinemisk clamp (EHC under 180 min under vilken 
kardiovaskulära parametrar mättes. Blodtryck och hjärtfrekvens mättes före och under 
infusionen och hovtemperatur (ett indirekt mått på blodflöde i hoven) mättes kontinuerligt med 
start 45 min före infusionens början. Seruminsulin och –glukos mättes under EHC, och 
insulinkänslighet bestämdes genom uträkning av metaboliserat glukos per enhet insulin (M/I-
kvot, där ett värde <5 benämns som resistenta). Hästarna hullbedömdes enligt Hennekes skala 
för body condition score (BCS). 
 
Resultat: Vilohjärtfrekvensen var högre hos insulinresistenta hästar jämfört med kontroller, 
och det fanns ett positivt samband mellan hjärtfrekvensen i vila och hög BCS.  Ingen skillnad i 
blodtryck eller hovtemperatur sågs mellan friska och insulinresistenta hästar. Under 
insulininfusionen sjönk systoliska blodtrycket hos kontrollerna men var oförändrat hos de 
insulinresistenta hästarna. Ingen skillnad från ursprungsvärdena sågs i hjärtfrekvens, 
medelartärtryck, diastoliskt tryck eller hovtemperatur i någon av grupperna under infusionen.  
 
Konklusion: Studien indikerar att insulinresistenta hästar har högre vilohjärtfrekvens än hästar 
med normal insulinkänslighet. Vilohjärtfrekvens var också associerad till grad av fetma, där 
feta hästar tenderade att ha högre hjärtfrekvens i vila. Det finns också indikationer på att 
insulinresistenta hästar har ett förändrad kardiovaskulärt svar på insulininfusion jämfört med 
friska insulinkänsliga kontroller. Fler studier på ett större material av hästar av olika raser är 
nödvändiga för att bekräfta detta samband. 
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ABBREVATIONS 
AUC  Area under the curve 
BCS  Body condition score 
BP  Blood pressure 
CNS  Cresty neck score 
DBP  Diastolic pressure 
EHC  Euglycemic-hyperinsulinemic clamp 
EMS  Equine Metabolic Syndrome 
ET-1  Endothelin-1 
GLUT  Glucose transporter 
HR  Heart rate 
HWST  Hoof wall surface temperature 
IR   Insulin resistant / insulin resistance 
IS  Insulin sensitive 
MetS  Human Metabolic Syndrome 
MAP  Mean arterial pressure 
NO  Nitrous oxide 
OGT  Oral Glucose Test 
PBF  Peripheral blood flow 
pEHC   prolonged Euglycemic-hyperinsulinemic clamp 
PPID  Pituitary Pars Intermedia Dysfunction 
RAAS  Renin-Angiontensin-Aldesteron-System 
SBP  Systolic blood pressure 
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INTRODUCTION 
Insulin resistance (IR) is a key feature of Equine Metabolic Syndrome (EMS) and Pituitary Pars 
Intermedia Dysfunction (PPID). Both diseases increase the risk of laminitis (Frank et al., 2010). 
Laminitis is a detrimental disease of the hoof, causing pain, lameness and often leads to 
euthanasia (Johnson et al., 2009). EMS has a counterpart in human medicine, human metabolic 
syndrome (MetS). The syndromes both include IR, obesity and dyslipidemia (Frank, 2011).  
 
Insulin is a hormone produced by pancreatic β-cells, which besides its central metabolic 
function also has vasoactive effects (Kim et al., 2006; Sjaastad, 2010). It acts primarily 
vasodilating, to increase postprandial glucose uptake in peripheral tissue, but can also cause 
vasoconstriction (Kim et al., 2006). The physiological response to insulin is highly 
sophisticated, with vasoconstriction and vasodilation acting in balance through different 
mechanisms (Younk et al., 2014). Hyperinsulinemia has been shown to increase peripheral 
blood flow (PBF), lower blood pressure (BP) and increase heart rate (HR) in studies on healthy 
people, dogs and rats, however conflicting results exists (Anderson et al., 1991; Baron and 
Brechtel, 1993; Bourgoin et al., 2008; Hall et al., 1995, Santure et al., 2002; van de Borne et 
al., 1999). 
 
Under IR conditions, the vasodilating effects of insulin are impaired through multifaceted 
changes in cellular signaling pathways (Kim et al., 2006; Younk et al., 2014). Elevated blood 
pressure is a vital part of human MetS, and higher baseline BP and/or HR has been shown in 
IR rats and dogs (Bourgoin et al., 2008; Hall et al., 1995). The acute hyperinsulinemic effect 
on HR, BP and PBF on IR subjects is controversial, with studies showing no difference between 
healthy or IR, or an impaired effect of insulin infusion (Baron and Brechtel, 1993; Bourgoin et 
al., 2008; Hall et al., 1995; Laakso et al., 1990; Santure et al., 2002).  
 
Studies regarding the effect of insulin resistance and induced hyperinsulinemia on 
cardiovascular markers in horses are scarce. A study on previously laminitic ponies showed 
that they had higher baseline blood pressures during summer pasture than ponies with normal 
insulin sensitivity, and that this was associated with a decreased insulin sensitivity (Bailey et 
al., 2008). In healthy insulin sensitive horses, no effect of insulin infusion was shown on HR, 
but an increase in PBF was seen (with a decrease in variation in PBF compared to healthy 
controls) (de Laat et al., 2010). Blood pressure has been shown to decrease during induced 
hyperinsulinemia in healthy horses (Nostell et al., 2016).  
 
The purpose of this study was to compare heart rate, blood pressure and hoof wall surface 
temperature (HWST) in insulin resistant horses with controls and to study the effect of 
hyperinsulinemia. The hypothesis, based on previous studies, is that baseline systemic blood 
pressure is higher in IR horses than in insulin sensitive horses. Another hypothesis was that 
hyperinsulinemia would decrease systemic blood pressure and increase HWST in both groups 
of horses, with changes seen to a lesser extent in IR horses.  
 
In this paper, the review of the literature is focused on the physiological and pathological role 
of insulin in healthy and resistant individuals. The literature review will begin with a short 
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description of clinical relevance of IR in horses, and then discuss insulin and its physiological 
and pathological vascular effects. Finally, existent studies on cardiovascular markers during 
hyperinsulinemia (and the pathophysiology behind it) will be presented. 
 
LITERATURE REVIEW 
Insulin and insulin resistance – clinical relevance 
Insulin resistance in horses is defined as “a reduction in the action of insulin on target tissues” 
(Frank, 2011). Insulin is an anabolic hormone that increases cellular glucose uptake, 
triglyceride and glycogen synthesis while inhibiting gluconeogenesis and lipolysis (Kim et al., 
2006). Besides the key role in metabolism, insulin has a wide array of different physiological 
functions including anti-inflammatory effects and regulation of the vascular tone (Geor, 2008). 
The metabolic and vasoactive effects of insulin are synchronized to optimize postprandial 
clearance of glucose from the blood stream (Younk et al., 2014).  
 
Diagnosis of insulin resistance 
Diagnosis of IR in horses can be made using static/screening or dynamic tests (Frank, 2011; 
Johnson et al., 2012). Static tests (i.e. resting serum insulin and glucose concentration) are less 
sensitive than dynamic. Dynamic tests measure the metabolic response in serum glucose and 
insulin to a glucose challenge. Many of the dynamic tests are labour-time-intensive and are 
primarily used for research purposes, i.e. Euglycemic-Hyperinsulineamic Clamp (EHC) and 
Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT). These two tests are 
considered as the Gold Standard for IR diagnosis (Johnson et al., 2012). The Combined 
Glucose-Insulin Test (CGIT), the Oral Sugar Test (OST)  and the Oral Glucose Test (OGT)  are 
all examples of dynamic tests used in the clinical setting (Eiler et al., 2005; Lindåse et al., 2015; 
Schuver et al., 2014). These tests are made by measuring plasma glucose and insulin after a 
single administration of oral or intravenous glucose (with or without insulin). Insulin resistance 
can be quantified using the M/I ratio, which is a method for approximating the amount of 
glucose metabolized per unit of insulin, which is lower in an IR subject (DeFronzo et al., 1979). 
The M/I ratio is calculated from serum insulin and glucose levels obtained during an EHC.  
 
Insulin resistance and endocrine pathologies 
Insulin resistance is a known characteristic in two endocrine diseases of the horse: Equine 
Metabolic Syndrome (EMS) and Pituitary Pars Intermedius Dysfunction (PPID). Laminitis is a 
key feature of both these diseases.  
 
Insulin resistant horses have an increased risk of laminitis (Frank, 2011; Johnson et al., 2010). 
Serum insulin levels have been found to be strongly correlated with laminitis score in both 
healthy and EMS/PPID horses (Walsh et al., 2009).  Laminitis associated with PPID or EMS is 
called endochrinopathic laminitis, the exact mechanism of which is still elusive. Different 
mechanisms have been proposed to cause laminitis such as inflammation, vascular/endothelial 
dysfunction, extracellular matrix degradation and glucose dysregulation (Johnson et al., 2010; 
de Laat et al., 2010).  
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The term EMS was first presented by Johnson in 2002, describing a disease in obese horses 
with glucose intolerance, insensitivity to insulin and a predisposition to laminitis (Johnson, 
2002). The name of the disease was chosen from similarities with Human metabolic syndrome, 
as both conditions involve IR, obesity and dyslipidemia (Frank, 2011). Diagnosis of human 
MetS is based on the presence of three or more out of the following factors; abdominal obesity, 
elevation of serum triglycerides and glucose, elevated blood pressure and reduced levels of 
HDL cholesterol (Grundy, 2016).  
 
Equine Metabolic Syndrome has later been defined by a consensus statement by the American 
College of Veterinary Internal Medicine in 2010. It was then established that the diagnosis of 
EMS should be based upon the presence of IR, (characterized by hyperinsulinemia or an 
abnormal response to glucose or insulin), increased adiposity or obesity, and a predisposition 
to laminitis (Frank et al., 2010). Additional features are presence of dysplipidemia, 
hyperleptinemia, arterial hypertension and systemic inflammation (Frank et al., 2010; Johnson 
et al., 2012). Horses with EMS also have an increased risk of developing hyperlipidemia with 
secondary hepatic lipidosis (Johnson et al., 2012). Unlike in people, horses with IR seldom 
develop type 2 Diabetes Mellitus (DM) (Johnson et al., 2012). Management of EMS is focused 
on diet and increased activity, while pharmaceutical management needs further evaluation 
(Frank, 2011; Frank et al., 2010; Menzies-Gow, 2015). For detection of obesity and increased 
adiposity in horses, two body scoring systems have been developed. Body condition score 
(BCS) is obtained by appreciating the amount of palpable fat cover present in six regions on 
the body of the horse (Henneke et al., 1983). Evaluation of subcutaneous fat in the neck region 
of horses can be made using the Cresty neck score (CNS) (Carter et al., 2009a). Both CNS and 
BCS have been shown to have a good correlation to serum insulin levels (Carter et al., 2009a). 
 
Vascular effects of insulin - physiological 
Insulin is a vasoactive substance which stimulates both vasoconstriction and vasodilatation. 
Vasodilatation is initiated by the release of nitric oxide (NO) from endothelium, which relaxes 
vascular smooth muscle cells, thereby increasing blood flow (Younk et al., 2014). Nitrous oxide 
also has anti-inflammatory and anti-platelet migration effects (Younk et al., 2014). The release 
of NO as well as the metabolic effects of insulin is obtained through signaling in the PI-3 kinase-
dependent transduction pathway in skeletal muscle and adipose cells (Kim et al., 2006). 
Vasodilation acts biphasically; studies on people and rats have shown that capillary recruitment 
occurs after a few minutes and increased regional blood flow can be seen after 30 minutes 
(Baron et al., 1996; Coggins et al., 2001; Kim et al., 2006; Vincent et al., 2002). The 
physiological objective is to increase vascular access to peripheral cells for maximum blood 
glucose uptake.  
 
During normal conditions, insulin regulates vascular tone by balancing vasodilation (by 
increased NO-release) and vasoconstriction. Vasoconstriction is stimulated through secretion 
of endothelin-1 (ET-1) from endothelium in a separate, MAP-kinase dependent pathway (Younk 
et al., 2014). Insulin also has an effect on the sympathetic nervous system leading to increased 
blood pressure through the vasoconstrictive effects of catecholamines (Kim et al., 2006). In an 
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insulin sensitive individual, acute hyperinsulinemia leads to a balanced effect of NO and ET-1 
and sympathetic tone, and does not result in hypertension.  
 
Vascular effects of insulin - pathological 
Insulin resistance suppresses the vasodilating effects of insulin (Younk et al., 2014). In two 
studies on rats (ex and in vivo) and people, IR has been shown to only interfere with the effect 
of insulin on the PI-3 kinase signaling pathway while the MAP-kinase signaling pathway is 
unaffected, thus leaving vasoconstriction as the only attainable effect of insulin (Cusi et al., 
2000; Jiang et al., 1999). When IR conditions apply, acute hyperinsulinemia results in 
decreased NO production, shifting the balance towards ET-1 secretion and vasoconstriction 
(Younk et al., 2014).   
 
Exactly what causes tissue to become resistant to insulin is unknown. However, the mechanisms 
behind insulin resistance have been extensively studied in human medicine, and the theories 
centers around endothelial dysfunction and obesity-related inflammation (Kim et al., 2006). 
Endothelial dysfunction has been proposed as an important part of human MetS as well as EMS 
in a review (Geor and Frank, 2009). Endothelial dysfunction is characterized by increased 
production of reactive oxygen agents (ROS) and cell adhesion products as well as a decreased 
ability for vascular relaxation (Geor, 2008). Glucotoxicity and lipotoxicity due to elevated free 
fatty acids (FFAs) in DM-patients can cause both IR and endothelial dysfunction (Kim et al., 
2006). Inflammation and pro-inflammatory conditions lead to an impairment of the PI-3 cell 
signaling pathway leading to IR. Human diseases causing endothelial dysfunction (e.g. 
atherosclerosis) leads to increased release of inflammatory proteins, which markedly decreases 
the endothelium’s response to NO. In this way, inflammation, IR and endothelial dysfunction 
have a reciprocal relationship, where the causality is far from straightforward (Kim et al., 2006). 
 
Cardiovascular effects of hyperinsulinemia with or without insulin resistance 
Physiological homeostasis of BP and HR is interconnected. Mean arterial pressure is the 
product of cardiac output (CO) and total peripheral resistance (TPR), and CO is in turn the 
product of heart rate and stroke volume, meaning an increase in blood volume leads to a rise in 
MAP (Sjaastad, 2010). Peripheral vasoconstriction leads to an increase in TPR and 
consequently in MAP. Total peripheral resistance is subject to neuro-hormonal regulation, with 
increased sympathetic activity and circulating epinephrine/norepinephrine leading to an 
increase in vasoconstriction and a rise in TPR. Arterial resistance is also subject to 
autoregulation by organs and the endothelium itself, independent of neuro-hormonal influence. 
In the long term, a major part of blood pressure regulation occurs through the renin-angiotensin-
aldesterone system (RAAS), where a decrease of BP leads to increasing serum levels of 
Angiotensin II, Angiotensin II increases blood pressure by multiple mechanisms; through 
increased vasoconstriction as well as through an increase in blood volume; both due to increased 
renal resabsorption of fluids and an increase in thirst and thereby fluid intake (Sjaastad, 2010).  
 
Heart rate is also subject to neuro-hormonal regulation. Increase of sympathetic tone as well as 
increasing circulating serum levels of norepinephrine and epinephrine leads to higher HR.  In 
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contrast to BP, the parasympathetic system is also of importance in HR regulation. Changes in 
HR are generally mediated by concurring altered activity in both the sympathetic and the 
parasympathetic system (Sjaastad, 2010).  
 
Blood pressure 
Hypertension is a vital component of human MetS (Grundy, 2016). It has been proposed that 
several factors act together to elevate blood pressure; IR, enhanced renal absorption of sodium, 
increased intravascular volume, activation of renin-angiotensin-aldosterone-system (RAAS) 
and increased release of angiotensin from adipose tissue (Grundy, 2016). Also, as mentioned 
previously, IR contributes to endothelial dysfunction, with ROS leading to endothelium-
dependent decreased vasodilation and thus hypertension (Kim et al., 2006). Hyperinsulinemia 
under IR conditions has been proposed to lead to increased sympathetic tone as well as an 
unbalanced vasoactive activity regarding ET-1 and NO secretion (Younk et al., 2014). 
Increased blood pressure has been reported in horses with history of laminitis (Bailey et al., 
2008; Rugh et al., 1987). One study has shown that laminitis-prone ponies had a higher systemic 
blood pressure and lower insulin sensitivity during the summer months compared to healthy 
controls (Bailey et al., 2008). No significant difference was detected in a similar study on a 
herd of ponies, where systemic blood pressure and serum insulin levels were compared between 
laminitic, previously laminitic and healthy ponies  (Carter et al., 2009b).  
 
Hyperinsulinemia stimulates the sympathetic nervous system, but vasodilation occurring 
concurrently often cancels out a rise in blood pressure (Anderson et al., 1991; Scherrer and 
Sartori, 1997). The effect of acute hyperinsulinemia on systemic blood pressure has been 
studied in different species with conflicting results. Systemic blood pressure  decreased in 
horses after EHC, with a greater decrease seen in insulin sensitive horses compared to horses 
with IR (Nostell et al., 2016). No effect was seen in healthy and obese dogs during 
hyperinsulinemia (Hall et al., 1995; Villa et al., 1998). In healthy and IR rats, systemic blood 
pressure has been shown to be unchanged during EHC (Bourgoin et al., 2008; Santure et al., 
2002).  Baseline systemic blood pressure was found to be higher in obese rats and dogs 
(Bourgoin et al., 2008; Hall et al., 1995). In people, results are equally conflicting, with no 
changes detected during insulin infusion in healthy people in one study, while another found 
significantly lower MAP and DBP, but not SBP (Anderson et al., 1991; van de Borne et al., 
1999). MAP was found to decrease in lean but was unchanged in obese people (Baron and 
Brechtel, 1993). 
 
Heart rate 
Baseline heart rates have been shown to be higher in rats and dogs with induced IR and obesity 
(Bourgoin et al., 2008; Hall et al., 1995). No difference between baseline heart rates where 
shown between lean and obese IR people (Baron and Brechtel, 1993). 
 
In people, insulin infusion has been shown to lead to increased sympathetic activation and 
increased serum levels of norepinephrine which contribute to higher heart rates (Anderson et 
al., 1991; Sjaastad, 2010). No changes in heart rate were found in healthy horses with 
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hyperinsulinemia induced by glucose infusion or EHC (de Laat et al., 2010; de Laat et al., 
2012). Heart rate has been shown to increase in healthy dogs and dogs with obesity-induced IR 
dogs during hyperinsulinemia (Hall et al., 1995). No increase in heart rate was seen in healthy 
or IR rats (Bourgoin et al., 2008; Santure et al., 2002). Heart rate has been shown to increase 
in healthy people during EHC, but was reported to be unchanged in obese subjects (Anderson 
et al., 1991; Baron and Brechtel, 1993; van de Borne et al., 1999). 
 
Digital blood flow 
Peripheral blood flow in horses can be studied by measuring HWST, a method that has been 
shown to have good correlation with digital blood flow (Bailey et al., 2004; Menzies-Gow et 
al., 2008). In one study on healthy horses, horses receiving an EHC were shown to have 
increased HWST compared to horses receiving a saline infusion (de Laat et al., 2010). In the 
same study, variation in HWST was smaller in horses receiving an insulin infusion compared 
to saline. 
 
Hyperinsulinemia induced during an EHC has been shown to lead to higher PBF in several 
studies in insulin sensitive people and rats (Anderson et al., 1991; Baron and Brechtel, 1993; 
Baron et al., 1996; Baron et al., 1995; Laakso et al., 1990; van de Borne et al., 1999; Vincent 
et al., 2002).  Lean subjects were found to have higher peripheral blood flow than obese insulin 
resistant individuals (Baron and Brechtel, 1993).  
 
MATERIAL & METHODS  
The study was approved by the Animal Ethics committee of Uppsala, Sweden (no C19/14), and 
is part of a PhD project on Equine Metabolic Syndrome.   
 
Horses 
The study consisted of two study groups; healthy controls and horses diagnosed with IR. The 
IR horses included in the study were privately owned Icelandic horses diagnosed with IR using 
an OGT-test (insulin responses over 1500 ng/L) performed by field active veterinarians. Horses 
showed no signs of pain or laminitis upon examination at arrival or during the stay at the clinic. 
Controls were recruited from the population at Wången National Center for Education in 
Trotting. Inclusion criteria for the control group were healthy Icelandic horses age 4-15 with a 
BCS<7 and no previous history of laminitis. An OGT and EHC were performed on all control 
candidates, and subjects with an M/I ratio<5 were excluded. Horses (in both groups) with 
ATCH-concentrations above the reference range (<11 pmol/L August-October or <7 pmol/L 
November-July) were excluded from the study. 
 
Study protocol 
Studies on IR horses were performed at the Equine clinic at the University Animal Hospital, 
Swedish University of Agricultural Sciences, Uppsala. Studies on the control group were 
performed at Wången National Center for Education in Trotting. Studies on IR horses were 
performed from November 2014 throughout April 2015, and controls in December 2015. 
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Insulin resistant horses  
Each horse was housed in a separate stable together with another horse in order to minimize 
stress. Boxes were bedded with wood or paper shavings and the horses were strictly fed the 
same food regimen as in their home environment and had access to water at all times during the 
day. Horses were exercised by hand walking several times per day.  
 
All horses arrived at the clinic 3 or 4 days before the EHC (day 1).  The day after arrival (day 
2) an area over each jugular was clipped, and after antiseptic preparation and desensitizing with 
a topical local anesthetic (EMLA; Lidokain 25 mg/g + Pilokain 25 mg/g, Astra Zeneca AB), an 
indwelling intravenous catheter (Intranule 2.0 x 105 mm, Vygon Sweden AB) was introduced 
into one of the jugular veins. Catheters were flushed with sterile saline infusion (0,9% Sodium 
chloride, Fresenius Kabi). Horses were withheld feed overnight (12 h) but allowed free access 
to water. As this study was a part of a larger study regarding the reliability of the OGT-test, an 
additional OGT-test was performed in all horses on day 3. The results from this OGT test are 
not presented in this paper. After the OGT test the horses were allowed normal feed. The EHC 
was performed within 2 days after OGT. The day before EHC, an additional intravenous 
catheter was placed in the contralateral jugular in the same manner as described above, to 
provide one catheter for blood samples and one for insulin/glucose infusion. Horses were 
withheld feed for 12 hours before EHC but were allowed free access to water.  
 
Controls 
The EHC of the control horses were performed in the horses’ home environment with normal 
feed and exercise routines followed, except for 12 hours before OGT and EHC, where feed, but 
not water, was withheld for 12 hours. Otherwise, procedure for EHC was identical to the IR 
horses.  
 
Data collection 
EHC protocol 
The Euglycemic-hyperinsulinemic clamp (EHC) was performed as previously described 
(DeFronzo et al., 1979; Powell et al., 2002; Pratt et al., 2005). During the 180 minutes long 
EHC, the horses were infused with a continuous infusion of human insulin at 3 mU∙kg-1∙min-1 
(Humulin Regular, 100 IE/ml, Eli Lilly Sweden AB) and a 50% solution of glucose (500 mg/ml 
Glucose, Fresenius Kabi AB). The glucose infusion rate was adjusted to keep blood glucose at 
an euglycemic level (4.8-5.2 nmol/ml). Analysis of blood glucose was performed every five 
minutes using two hand held glucometers (Accu-Chek Aviva Plus Silver) for control of 
reliability of results. If measurements on the same sample differed more than 0.3 nmol/ml 
between the glucometers, samples were re-analyzed. Blood samples for subsequent analysis of 
plasma glucose and insulin were collected in lithium heparine tubes (Vacuette, Greiner Bio-
One) before the start of the EHC, every 10 min during the EHC as well as immediately after 
the EHC. Blood samples were kept cold on ice until centrifuged (within 15 minutes after 
sampling) at 2770 x g for 10 min, and then stored at –80 °C until analysis.  
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Hoof wall superficial temperature measurements 
Horses were fitted with a hoof temperature measuring equipment (Tinytag and PB-5003 unit, 
Intab) on the left front hoof. The method has been previously validated, and the equipment has 
been used in previous clinical studies on horses (de Laat et al., 2012, Hood et al., 2001). The 
measurement device was a probe that was attached to the dorsal hoof a few centimeters distally 
to the coronary band. Another measurement unit (Tinytag, Intab) was placed in the box to 
measure ambient temperatures. Measurements of room and hoof temperatures were started at 
least 45 min before the start of insulin infusion to allow the probe to adjust to room and hoof 
temperatures. Temperatures were registered automatically every two minutes during the entire 
EHC-clamp. Data were transferred to a computer program and compiled. 
 
Blood pressure measurement 
Systemic blood pressure and heart rate were measured using a non-invasive oscillometric 
technique via a sphygomanometer (Memo High Definition Oscillometry Monitor, horse model, 
S+B medVET GmbH) placed on the coccygeal artery. Both the method and device has been 
previously validated on horses (Muir et al., 1983; Söder et al., 2012; Tunsmeyer et al., 2015). 
Parameters provided by the test were MAP, SBP, DBP and HR. The horses were fitted with an 
8 cm cuff at the base of the tail, and measurements were made before, at 45 min, 105 min and 
165 min after the start of the insulin infusion. Measurements of distance from the base of the 
tail and the overlap of the cuff’s edges were noted to ensure consistent placement of the cuff. 
Six subsequent measurements of blood pressure were made at each time point. Several test 
measurements were made prior to data collection to allow the horses to get used to the testing 
procedure, and horses had also undergone BP measurements during OGT (not shown in this 
paper) on day 2. A first set of measurements with SBP higher than the subsequent, any set of 
values differing >20% in SBP and obviously faulty registrations were discarded, in line with a 
recommendation from small animal medicine (Brown et al., 2016). Mean values for MAP, SBP, 
DBP and HR were calculated from the remaining measurements.  
 
Scoring of body condition 
Subjective scoring of body condition (BCS) and cresty neck score (CNS) were made by the 
same experienced veterinarian. BCS was graded from 1 to 9 with 1 being extremely emaciated 
and 9 being extremely obese (Henneke et al., 1983). CNS was graded from 0 to 5 with 0 being 
no presence of a neck crest and 5 being a neck crest large enough to permanently fall to one 
side (Carter et al., 2009a).  
 
Blood samples and calculation of insulin sensitivity 
Plasma insulin from EHC was analyzed using a human commercial insulin ELISA (Mercodia 
Insulin ELISA, Mercodia AB) since exogenous human insulin was used during the infusion. A 
commercial insulin analysis kit (Mercodia Diabetes Antigen Control (Low/High), Mercodia 
AB) was used as an additional control test. Plasma glucose was analyzed with a clinical 
chemistry analyzer (YSI 2300 Stat Plus Analyzer, YSI Incorporated).  
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Insulin sensitivity was quantified by calculating the M/I-ratio (metabolized glucose per unit 
insulin, unit [mg/kg/min x 10^3] / [mU/I]) modified from Defronzo (1979), M being the 
metabolized glucose which is defined as follows: 
 
𝑀𝑀 = 𝐺𝐺𝐺𝐺𝐺𝐺 − 𝑆𝑆𝑆𝑆 
 
Where GIR = glucose infusion rate (mg ∙ kg-1∙ min-1) and SC is the space corrector, used to 
compensate for glucose removed from circulation by other means than metabolization, defined 
as follows: 
𝑆𝑆𝑆𝑆 = (𝐺𝐺1 − 𝐺𝐺2)𝑥𝑥 0,019  
 
Where G1=glucose concentration in the previous test, G2=glucose concentration in the 
subsequent test. M/I ratio is calculated during the last 60 minutes of the EHC, starting at 120 
minutes of insulin infusion. At this time, blood glucose levels have reached steady state. 
 
Statistical analysis 
Data was analyzed with a commercial statistical software (JMP Pro 12.2.0, SAS Institute Inc.) 
with statistical significance set at P<0.05. Means and standard errors (SE) were calculated and 
compared between groups for descriptive data (except M/I ratio). BCS, CNS and age were 
evaluated using the Student t-test and sex was analyzed using a Pearson test. Baseline HR and 
BP were compared using a Student t-test. Due to non-normality, M/I-ratio was analyzed by 
Wilcoxon test and presented by median and interquartile range.  
 
JMPs repeated measures mixed model analysis of variance (ANOVA) with AR(1) used as a 
repeated covariance structure (with horse set as subject) were used to compare heart rates and 
diastolic blood pressures over time and between groups of horses (IR horses vs controls). AR(1) 
is a repeated covariance structure which assumes measurements more closely related in time 
are more correlated than those further apart. Due to unequal variances between groups of horses 
for SBP and MAP, these data were analyzed separately for each group of horses using a repeated 
mixed model of ANOVA.  
 
Because of non-normality and heteroscedasticity of temperature data, HWST measurements for 
every 15 mins were transformed into temperature responses over 1 hour for 3 different time 
periods using area under the curve (AUC) (GraphPad Prism, Version 6.0, GraphPad Software 
Inc.). AUC data were then expressed as change from baseline calculated from measurements 
taken before infusion start.  Missing HWST values (n=3, from group IR) were extrapolated 
from the last obtained time points. Hoof temperature changes (ΔHWST-AUC) were analyzed 
using a mixed model, with group, time and group-time interaction as fixed effects, while room 
temperature changes (ΔRT) were analyzed by group with time as fixed effects. 
 
Tukey-Kramer was used as a post hoc test to compare least square means (LSMs) where 
statistical significance was found. Residuals were visually checked for normality.  
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Because of difference in baseline HR, a multiple regression analysis was made to find a model 
explaining the differences. In the multiple regression analysis model, analyses were performed 
in a backward stepwise manner, with age, M/I ratio, BCS, CNS and stress levels included as 
explanatory variables and HR as a dependent variable in the initial model. Due to unequal 
distribution between groups, sex was not included in the model. Variables with P<0.05 were 
removed until all that remained were significant. R2 of the resulting model is presented.  
 
RESULTS  
Horses 
Horse data for IR and control group are presented in table 1.  
 
Table 1. Characteristics of insulin resistant and control horses 
 
Control 
horses   
Insulin resistant 
horses   
N 4   10   
Sex: Mares 1*   9*   
Sex: Geldings 3*   1*   
Age 9.3 ± 2.1   13.9 ± 1.7   
BCS 5.3 ± 0.1*   6.8 ± 0.4*   
CNS 2.4 ± 0.1***   3.8 ± 0.2***   
M/I i 6.7 (6.2-7.8)*   1.7 (1.4-2.4)*   
Table 1: Number of horses, sex, age (years), body condition score (BCS), cresty neck score (CNS) and M/I ratio (unit [mg/kg/min 
x 10^3] / [mU/I]) for insulin resistant horses and controls. Values are expressed as means ± standard error, except i = median and 
interquartile range, */*** significantly different between groups, * = P<0.05, *** = P<0.0001. 
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Heart rate 
Mean heart rates were significantly higher in the insulin resistant group compared to controls 
as a main effect (P<0.05). Although mean heart rate increased numerically during insulin 
infusion in both controls and insulin resistant horses the increase was not statistically 
significant. Values are presented in table 2.  
 
In the multiple regression analysis, the only remaining significant factor was BCS, and a 
positive correlation between BCS and baseline heart rate was found. R2 for the final model was 
0.54 (P<0.05).  
 
Table 2. Heart rate in insulin resistant horses and controls before and during the insulin infusion 
 
 Control 
horses   
Insulin resistant 
horses    
Time  LSM SE  LSM SE  
0 28.2 2.2  35.8 1.7   
45 29.8 2.5  37.8 1.7   
105 30.0 2.9  38.3 1.7   
165 32.0 2.9  38.6 1.7   
Table 2. Least square means for heart rate (beats/min) in insulin resistant horses and controls at the start of insulin infusion (0), 
and at 45, 105 and 165 min of the insulin infusion. LSM: Least square means, SE: Standard error.  
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Blood pressure 
No significant differences in baseline systolic (SBP), mean arterial (MAP) or diastolic pressure 
(DBP) could be found between groups. In controls, systolic blood pressure decreased 
significantly during insulin infusion (P<0.05), but no significant decrease was seen in MAP or 
DBP. No significant change was seen during insulin infusion in the IR group.  
 
Measurement errors commonly occurred in horses in both groups, necessitating several 
refittings of tail cuffs. Refittings were made in accordance with measurements of cuff overlap 
and distance to tail base. 
 
Table 3. Blood pressures in insulin resistant horses and controls before and during the insulin infusion 
 
 Control 
horses   
Insulin resistant 
horses    
Time  LSM SE  LSM SE  
0 SBP 113 6.7  111 4.2  
 MAP 83 4.7  81 3.0  
 DBP 66 4.3  64 2.8  
45 SBP 104* 6.7  113 4.2  
 MAP 77 4.7  83 3.0  
 DBP 61 4.3  66 2.7  
105 SBP 102* 7.7  108 4.2  
 MAP 76 5.4  80 3.0  
 DBP 62 5.0  64 2.7  
165 SBP 99* 7.7  114 4.2  
 MAP 74 5.4  85 3.0  
 DBP 58 5.0  69 2.7  
Table 3. Least square means for systolic (SBP), mean arterial (MAP)- and diastolic blood pressure (DBP) in mmHg in insulin 
resistant horses and controls before insulin infusion (0) and at 45, 105 and 165 minutes during insulin infusion. * - significantly 
changed from baseline (P<0.05). LSM = Least square means, SE = standard error. 
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Hoof wall surface temperature 
In one of the IR horses, the hoof wall temperature sensor failed to give readings, and the result 
from this horse was therefore excluded.  
 
Response of HWST from baseline during insulin infusion did not reach significance in the 
individual groups. However, when comparing the groups, insulin infusion had a significantly 
different effect (P<0.05) on HWST in controls and insulin resistant horses at the last two time 
periods (2 and 3 h into the infusion), with a decrease seen in controls and a slight increase seen 
in IR horses. Data is shown in Fig. 1. 
 
Fig.1. Alterations in mean hoof wall surface temperatures in insulin resistant horses and controls 
during the insulin infusion 
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Fig 1. Mean response in area under the curve from baseline for hoof wall surface temperature (measured in °C ∙ min) during 
time period 0-1 h, 1-2 h and 2-3 h. Square markers represent insulin resistant horses and round markers represent control 
horses. Means ± standard error. Changes from baseline P= NS in the individual groups. 
 
DISCUSSION  
Heart rate, systemic blood pressure and HWST in insulin resistant horses and controls 
The results of this study show that baseline heart rate was higher in IR horses compared to 
controls and that the discrepancy between groups could be attributed to the differences in BCS. 
Many studies performed on people, rats or dogs include both IR and obese subjects, which 
makes separation of factors for comparison difficult. Obesity and IR are strongly related in 
people; one study in people found that higher insulin resistance was associated with higher body 
14 
 
mass index (BMI), and that 84% of subjects in the top IR tertile were either obese or overweight 
(McLaughlin et al., 2004). The results obtained in the present study is in agreement with studies 
on dogs and rats with induced obesity and IR where elevated baseline heart rates were seen 
compared to lean subjects (Bourgoin et al., 2008; Hall et al., 1995). Reports regarding obesity 
in people are conflicting; obese subjects have been reported to have equal to or slightly elevated 
baseline heart rates compared to lean individuals (Alpert et al., 2016). The pathophysiology of 
cardiovascular changes in hemodynamics related to obesity are decreased parasympathetic 
tone, increased sympathetic tone but also increased blood flow demands to non-adipose tissue 
as well as adipose tissue (Alpert et al., 2016; Hall, 2000).  
 
Obesity has also been demonstrated to be strongly related to the development of hypertension 
in people (Alpert et al., 2016; Hall, 2000). In addition to the increase in sympathetic activity 
mentioned above, hypertension in obesity and IR is believed to be caused by increased renin-
angiotensin-aldosterone system (RAAS) activation, increased renal natrium resorption as well 
as endothelial dysfunction and increased inflammatory activity in adipose tissue (Alpert et al., 
2016; Hall, 2000; Kim et al., 2006). Higher baseline blood pressure has been shown in dogs 
and rats with induced obesity and IR compared to lean controls (Bourgoin et al., 2008; Hall et 
al., 1995). The prevalence of hypertension in obese people is 50-60 % (Alpert et al., 2016). In 
the present study, there were no baseline differences in systemic blood pressure between insulin 
resistant horses and controls, even though heart rates were increased in the former group. 
However, the individual variation in blood pressure has a greater impact on the result in a study 
performed on a small material of horses. Therefore, the fact that the study was performed on a 
small material of horses makes it difficult to detect differences in blood pressure between 
groups which also might have influenced the results obtained. Studies on a larger material of 
insulin resistant horses and controls are necessary. Hypertension has been reported in IR horses, 
but few studies on equine obesity and hypertension exists to elucidate if the pathophysiology 
matches that reported in people and other animals (Bailey et al., 2008; Rugh et al., 1987). Bailey 
et al. (2008) showed that insulin resistance and blood pressure was higher in laminitis-prone 
ponies in June than in November-December, and that this difference was not evident in healthy 
controls. Pasture-associated laminitis is often seen in EMS horses. The pathophysiology behind 
this is still unknown but is thought to be related to increased intake of non-structural 
carbohydrates leading to hyperinsulinemia in IR subjects (Geor, 2008).  
 
No difference between baseline HWST was seen in IR horses compared to controls in the 
present study. One study has shown difference in baseline HWST between laminitic or 
laminitis-prone ponies and healthy controls, but also reported that ambient temperatures 
potentially confounded the results (Carter et al., 2009b). Baseline room temperatures were not 
different between groups in the present study, and did not change significantly during infusion 
in either group. 
 
Effects of hyperinsulinemia on heart rate, systemic blood pressure and HWST 
In line with our hypothesis and with results from de Laat (2010; 2012), no significant increase 
in heart rate during insulin infusion could be seen. Studies on insulin sensitive people as well 
as dogs have shown that insulin infusion causes an increase in heart rate (Anderson et al., 1991; 
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Baron and Brechtel, 1993; Hall et al., 1995; van de Borne et al., 1999). No corresponding 
change in HR (or BP) was seen in IR people by Baron & Brechtel (1993). In the present study, 
a numerically small but non-significant increase of HR from baseline was apparent in both 
groups. A greater number of study subjects might have elucidated the difference between 
groups, which might be masked by large individual variations.  
 
Insulin infusion caused a decrease in SBP in controls but not IR horses. This decrease in SBP 
during insulin infusion was also shown in a study by Nostell et al. (2016). The difference in the 
cardiovascular response to insulin between groups might be attributed to the effect of insulin 
resistance on NO-mediated vasodilation (Scherrer and Sartori, 1997). Increased peripheral 
blood flow during insulin infusion has been seen in many studies on people (Anderson et al., 
1991; Baron and Brechtel, 1993; Baron et al., 1995). Activation of PI-3 signaling pathways 
have been shown to be strongly decreased in IR rats and people compared to controls, 
potentially inhibiting vasodilation and subsequent decrease in blood pressure (Cusi et al., 2000; 
Jiang et al., 1999). Insulin resistant  subjects have been reported to require four times higher 
serum insulin concentrations to achieve the same peripheral blood flow as IS subjects (Laakso 
et al., 1990). However, increased vasodilation does not always lead to decreased systemic blood 
pressure, as showed during EHC in healthy people (van de Borne et al., 1999). The complexity 
of the effect of insulin on hemodynamics and vasculature makes prediction of response to 
hyperinsulinemia difficult, and there might be great variation between subjects depending on 
insulin sensitivity.  
 
In the present study, insulin infusion did not cause a simultaneous decrease in MAP or DBP. 
This is in contrast with another study in horses where insulin infusion caused a concurrent 
decrease in MAP and DBP (Nostell et al., 2016). In addition to this, a study in people showed  
decreases in MAP and DBP, but not SBP, during an EHC (Anderson et al., 1991). The reason 
for this discrepancy in results is likely to related to the blood pressure measurement device used 
in the present study, which has been shown to have a higher CV (a higher between-
measurements variance) for diastolic than systolic measurements (Söder et al., 2012). Several 
horses in both IR and control group had low diastolic values (DBP < 60). Low diastolic values 
might be a common trait in the breed, with earlier studies on Icelandic horses reporting SBP 
105±14 mmHg and DBP 66 ±17 mmHg (Söder et al., 2012). The values obtained in the present 
study are however in the normal interval reported in horses (Parry et al., 1984). Furthermore, 
Söder et al., (2012) showed that Icelandic horses had lower serum cortisol levels than 
Standardbreds. Cortisol is involved in blood pressure regulation, with excessive secretion 
leading to hypertension (as seen in human Cushing’s syndrome) and impaired secretion leading 
to hypotension (as seen in human Addison’s  disease) (Hammer and Stewart, 2006; Whitworth 
et al., 2005). This could implicate that the lower serum cortisol level seen in Icelandic horses 
could have a correlation to their lower blood pressures. Since low DBPs were a feature in both 
groups, this is not likely to have influenced the results. The low values could also be attributed 
to difficulties in measurements. The fact that all horses in the study were of a breed known for 
its thick tail sometimes made cuff placement difficult and several refittings were required for 
many subjects, increasing the risk of inconsistent placement. However, care was taken to ensure 
consistency by measuring and noting the cuffs’ overlap and distance to tail base. Blood pressure 
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values might be underestimated if the cuff is too wide, which (due to the thickness of the tails) 
seems less likely in this case (Latshaw et al., 1979). 
 
A significantly different effect of insulin infusion on hoof wall surface temperature was seen 
between groups (with controls having a decrease of HWST and IR a slight increase). This 
decrease of PBF in healthy individuals is contrary to what was seen by de Laat (2010), and in 
many human studies (Anderson et al., 1991; Baron and Brechtel, 1993; Baron et al., 1996; 
Baron et al., 1995; Eggleston et al., 2007; van de Borne et al., 1999). However, the result in 
HWST in the individual groups should be interpreted carefully since the responses in the 
individual groups from baseline are nonsignificant, and the number of subjects in the control 
group (n=4) is low. Sources of error in HWST measurements are erroneous placement of 
probes, detachment of probes over time due to adhesive tape coming loose or variability 
between individuals due to weight shifting. Differences in insulin infusion rates have been 
shown to influence tissue insulin sensitivity and serum insulin concentrations in healthy horses 
(Urschel et al., 2014). The infusion rate in de Laat (2010) was twice the rate in the present 
study. Different insulin rates have been used during EHC in the human studies quoted, all 
resulting in variations in serum insulin concentrations and potentially different results 
(Anderson et al., 1991; Laakso et al., 1990). In addition, time aspects are of importance when 
comparing studies. In the study by de Laat (2010), no differences in HWST between groups 
were seen until 11-15 h into EHC. If the lower insulin infusion rate used in the present study 
resulted in lower serum insulin concentrations (and consequently a slower increase in PBF), no 
differences in HWST might have been detected over the 3 h the present study lasted. The time 
course for insulin’s cardiovascular effects have not been established in horses, but in people, 
increases in PBF have been reported at 30-100 minutes into EHC (Baron et al., 1996; Eggleston 
et al., 2007; Laakso et al., 1990). Indirect measurement methods like HWST generally have 
decreased sensibility to detect changes in PBF compared to direct measurements 
(plethysmography) used in human studies (Anderson et al., 1991; Baron and Brechtel, 1993). 
HWST might have greater risk of measurement errors (e.g. by misplacements of sensors) than 
other indirect measurement of blood flow (Doppler ultrasonography) used in equine studies 
(Bailey et al., 2004; Menzies-Gow et al., 2008).  
 
Hyperinsulinemia (obtained by either prolonged EHC or glucose infusion) has been shown to 
induce laminitis in healthy horses (Asplin et al., 2007; de Laat et al., 2010; de Laat et al., 2012). 
Both increased and decreased HWST has been shown when laminitis was induced by 
hyperinsulinemia, carbohydrate overload or lipopolysaccharide-infusions in healthy horses 
(Hood et al., 2001; Menzies-Gow et al., 2004; Menzies-Gow et al., 2008; Pollitt and Davies, 
1998). However, although in vivo studies are lacking, several ex vivo/in vitro studies has been 
made on IR horses during hyperinsulinemia, where an increase of vascular resistance have been 
shown in IR tissues compared to controls (Gauff et al., 2013; Venugopal et al., 2011). In 
addition, several studies has shown that equine digital veins are more responsive to 
vasoconstriction by ET-1 than arteries (Katz et al., 2003; Peroni et al., 2006; Stokes et al., 2006; 
Venugopal et al., 2014). This tendency for increased venoconstriction is hypothesized to be of 
importance in laminitis pathophysiology as venous vasoconstriction could lead to stasis of 
digital vasculature, increase hydrostatic pressure and subsequent edema and digital ischemia 
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(Stokes et al., 2006).  Also, increased activity of arterio-venous anastomoses shunting blood 
away from the lamellar microvasculature is hypothesized to lead to digital ischemia despite 
evidence of increased blood flow (Asplin et al., 2007). These theories are interesting in regards 
to HWST because theoretically, vascular disturbances causing lamellar tissue hypoperfusion 
leading to laminitis could lead to HWST either decreasing (due to vasoconstriction of digital 
blood vessels) or increasing (due to an increase in arterio-venous anastomoses that shunts blood 
from microvasculature despite increased DBF, or due to stasis and edema).  
 
Limitations of the study 
Small sample sizes are an issue in this study. Cohesive groups were prioritized over number of 
participants and therefore only Icelandic horses were included to minimize between-breed 
difference, since characteristics of IR has been shown to vary among horse breeds (Bamford et 
al., 2014). Starting out with six control horses, two were eliminated due to decreased insulin 
sensitivity which became apparent when M/I ratios were calculated. Ideally, since HWSTs are 
known to physiologically vary over time (for example due to weight shifting) additional IR and 
healthy horses could have been used as a separate control group receiving a placebo infusion. 
This was done in the study by de Laat (2010), where horses receiving saline infusion were 
shown to have a larger variation in HWST compared to EHC horses.  
 
Preferably, the groups should have been better matched in several aspects, including sex, 
although no sex predilection has been found (Johnson, 2002). Inherent to the study recruitment 
method characteristics of horses differed between groups. Control horses belonged to Wången 
National Center for Education in Trotting and were used in training therefore required to be 
healthy and athletic. In contrast, IR horses were recruited with the aid from field active 
veterinarians and consequently were privately owned with varying health and athleticism. Feed 
also differed between individuals and between groups. 
 
Control horses were studied in their home environment while IR horses were housed at the 
Equine clinic. Although horses were allowed minimum 2 days of acclimatization before EHC 
was performed, baseline stress could still be higher in IR horses due to the new environment, 
which could affect HR and BP.  
 
CONCLUSION 
This study indicates that horses with insulin resistance have higher baseline heart rates 
compared to controls and that heart rate is associated with BCS.  There are also indications that 
insulin resistant horses might have an altered cardiovascular response to hyperinsulinemia, 
apparent as a decrease in SBP in control horses compared to IR. Since few other studies exist 
on EHC in IR horses compared to controls, further studies are needed to validate this result, 
preferably with greater sample sizes and using different breeds. Hopefully, more research on 
this subject could lead to a deepened understanding of cardiovascular influence of IR and take 
us a step closer towards management and prevention of EMS and endochrinopathic laminitis.  
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